Biosimilar Panel

Materials (25 pages PDF) 

Title:  Hot Topics and Issues in the Biosimilars Space

Things are moving quickly in the area of biosimilars.  The panel will highlight recent case law and provide commentary from both the brand and biosimilar perspective on future application of the BPCIA.  The FDA is front and center so regulatory issues will be addressed and the need for additional legislation will be considered.  The pros and cons of using IPRs on patents involving biologics will be emphasized.  

Please join us for an active and engaging discussion on the future of biosimilars.

Panelists
Terry Rea, Partner, Crowell & Moring; Former acting and deputy director of the United States Patent and Trademark Office (USPTO)
Robert M. Isackson, Partner, Orrick, Herrington & Sutcliffe LLP
Chad Landmon, Partner, Axinn, Veltrop & Harkrider LLP
David Leichtman, Partner, Robins Kaplan LLP

Moderator: Abigail Langsam, Counsel, Kaye Scholer LLP

Program Schedule
6:00 p.m. – 6:30 p.m. Registration & Pre-reception
6:30 p.m. – 7:30 p.m. Presentation 
7:30 p.m. – 8:00 p.m. Post-reception sponsored by Axinn